🔎 Trials Near Me

Home › Dermatomyositis › Texas

Dermatomyositis clinical trials in Texas

6 studies for Dermatomyositis are looking for participants at sites in Texas.

Cities in Texas

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • and 2 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • University of Texas Southwestern Medical Center - Accepting Juvenile Patients, Dallas
  • Houston Methodist Hospital - Accepting Adult Patients, Houston
  • University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston
RecruitingPhase 2/3
Ages 6 to 75 · All sexes · Updated Sep 17, 2026 · NCT06154252

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

  • Integrative Rheumatology of South Texas, Edinburg
  • Arthritis & Rheumatology Research Institute, PLLC, Frisco
  • Integrative Rheumatology of South Texas, Harlingen
  • and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT05895786

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

  • Arthritis & Rheumatology Research Institute, PLLC, Frisco
  • Nerve & Muscle Center of Texas, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06698796

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

  • Austin Neuromuscular Center, Austin
  • Nerve and Muscle Center of Texas, Houston
RecruitingPhase 1
Ages 18 to 85 · All sexes · Updated Jul 22, 2026 · NCT06371417

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.